Delivery Order SPE2DB20D3505-SPE2DB22FT8E8

Award Date 5/18/22
Potential Completion Date 5/19/22
Potential Value $2.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Risperidone 1 mg tablets. The contract, valued at $1,270.18, is a firm fixed price delivery order with a completion date of June 10, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This federal contract award, valued at $1,032.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4559089829 - Risperidone 2 mg tablets in 60s. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Risperidone 0.5 mg tablets in 500-count bottles. The $1,276.62 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,796.85 firm-fixed-price delivery order is for the supply of 4,563,983,413 Risperidone 2 mg tablets. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,543.76 for the supply of 4,562,032,334 units of Risperidone 2 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 5, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,072.55 for the supply of Risperdal 1 mg tablets. The contract was awarded on April 21, 2022, by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for delivering the pharmaceutical product to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.25 mg Risperidone tablets. The $1,715.80 firm-fixed-price contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has extensive experience providing pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,853.28, is for the delivery of 500 tablets of 0.5 mg Risperidone, a prescription medication. The award has an ultimate completion date of October 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 through December 2025, which AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 1 milligram risperidone tablets in 500-count packages. The delivery order has a firm fixed price of $8,527.17 and a performance period ending on May 8, 2023. This award is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.11 firm fixed-price delivery order is for the supply of Risperidone 2 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of May 12, 2023 and was awarded on May 11, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB22FT8E8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4557273330 - Risperidone 2 mg Tablets, 500 count. The award has a ceiling value of $2,671.78 and was issued on May 18, 2022, with a completion date of May 19, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded through full and open competition and does not have a set-aside designation.

Generated 2/27/25, 11:47 AM